Ushbu ish iqtibos qilgan ishlar

15 ta ish

Ish: Prevalence and epidemiology of hepatitis B and hepatitis D in Uzbekistan—results from a population-based serosurvey, 2022

1. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020

   Rick Dunn, Erkin Musabaev, Homie Razavi +7

   MaqolaOAOchiq kirish20208 iqtibos

   ABIABI:AkademIndex/2026.other.114019

2. Viral hepatitis elimination challenges in low‐ and middle‐income countries—Uzbekistan Hepatitis Elimination Program (UHEP)

   Erkin Musabaev, Chris Estes, Shakhlo Sadirova +10

   MaqolaOAOchiq kirishHepatitis B Virus StudiesLiver International20238 iqtibos

   ABIABI:AkademIndex/2026.other.117944

3. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

   Devin Razavi-Shearer, Ivane Gamkrelidze, Mindie H Nguyen +97

   Sharh maqolaOAOchiq kirish20186 iqtibos

   ABIABI:AkademIndex/2026.other.197012

4. The Disease Burden of Hepatitis B in Uzbekistan

   Philippe Beutels, Erkin Musabaev, Pierre Van Damme +1

   MaqolaHepatitis B Virus StudiesJournal of Infection20005 iqtibos

   ABIABI:AkademIndex/2026.other.196999

5. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

   Devin Razavi‐Shearer, Ivane Gamkrelidze, Calvin Q. Pan +97

   Maqola20234 iqtibos

   ABIABI:AkademIndex/2026.other.419454

6. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association

   Vivian Hope, Irina Eramova, Diego Alberto Capurro +1

   Sharh maqolaOAOchiq kirish20133 iqtibos

   ABIABI:AkademIndex/2026.other.197002

7. Hepatitis D virus in Uzbekistan

   Malika Khodjaeva, Nargiz Ibadullaeva, Aziza Khikmatullaeva +7

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.546558

8. Prevalence of chronic hepatitis B virus infection among children in Uzbekistan: Impact of vaccination

   Nino Khetsuriani, Dilorom Tursunova, Rano Kasimova +7

   MaqolaOAOchiq kirishHepatitis B Virus StudiesVaccine20252 iqtibos

   ABIABI:AkademIndex/2025.article.001693

9. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity

   Jördis J. Ott, Gretchen A Stevens, Justina Groeger +1

   Sharh maqola20122 iqtibos

   ABIABI:AkademIndex/2026.other.440811

10. A mathematical model to estimate global hepatitis B disease burden and vaccination impact

    Susan T. Goldstein, Fangjun Zhou, Stephen C. Hadler +3

    Maqola20052 iqtibos

    ABIABI:AkademIndex/2026.other.440814

11. Natural history and treatment of chronic delta hepatitis

    Cihan Yurdaydın, Ramazan Idılman, Hakan Bozkaya +1

    Sharh maqola20102 iqtibos

    ABIABI:AkademIndex/2026.other.696913

12. Prevalence of hepatitis B surface antibody among previously vaccinated healthcare workers in Tashkent, Uzbekistan

    Rafail Ibragimov, Dilyara Nabirova, Alfiya Denebaeva +2

    MaqolaOAOchiq kirishHepatitis B Virus StudiesHuman Vaccines & Immunotherapeutics20241 iqtibos

    ABIABI:AkademIndex/2024.article.002532

13. Awareness, knowledge, and practices related to hepatitis B and hepatitis C in the Republic of Uzbekistan—Results from a population-based survey, 2022

    Rania A. Tohme, Shaun Shadaker, Elizaveta Joldasova +7

    MaqolaOAOchiq kirishHepatitis C virus researchBMC Public Health20261 iqtibos

    ABIABI:AkademIndex/2026.article.000224

14. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.880694

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.880695